Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Taps Former Hill Staffer Easton To Head Affordability, Access Group

This article was originally published in The Pink Sheet Daily

Executive Summary

Michelle Easton will oversee advocacy efforts on a wide range of programs and will work closely with health care partners in the newly created role of VP-group on affordability & access. She was a legislative assistant for former Rep. (now PhRMA CEO) Tauzin before working in former Sen. Breaux’s office for eight years.

You may also be interested in...



PhRMA Makes It Official: Rep. Tauzin Takes Over As CEO Jan. 3

Chief of Staff Simoneaux and Communications Director Johnson are expected to move with Tauzin to PhRMA. The Louisiana Republican's battle with intestinal cancer will allow him to discuss his personal stake in the future of the industry as its top spokesman.

PhRMA Agenda For 2005 Includes Medicare Start-Up, Liability Reform

Trade association will work on medical malpractice issues particularly at the state level. "Access & Affordability" initiative includes support for expanding coverage to the uninsured, and continued efforts around patient assistance programs.

PhRMA "Re-Repositioning"? Working Group Studying Rx Affordability Ahead Of Annual Meeting

Pfizer exec Katen is overseeing group studying access and affordability issues. Association hopes to build on spirit of "repositioning" work that led to marketing guidelines in 2002.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel